Събития за 04.11.2019

Leading experts in the field will present the key findings of these important studies, summarise the results, and provide a critical appraisal of the data. The Session will focus on: + PARP combination studies: PRIMA/PAOLO-1/ANVANOVA2 + First line ovarian cancer trials: VELIA/Forward1 + Lessons learned from gynaecological cancer trials: EWOC-1/EORTC55944/ PORTEC-3 The results of this research will be set in context of other trials, and how the results can influence future treatment approaches of gynaecological cancers.